NASDAQ: INMBInmune Bio Inc Stock Ownership - Who owns Inmune Bio?
Insider buying vs selling
Have Inmune Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David J. Moss | Chief Financial Officer | 2024-09-30 | 10,000 | $5.29 | $52.87kBuy |
| David J. Moss | Chief Financial Officer | 2024-09-12 | 7,690 | $6.38 | $49.02kBuy |
| Raymond Joseph Tesi | President and CEO | 2024-09-12 | 15,380 | $6.38 | $98.05kBuy |
| Scott Juda | Director | 2024-06-25 | 5,000 | $7.27 | $36.35kBuy |
INMB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INMB insiders and whales buy or sell their stock.
INMB Shareholders
What type of owners hold Inmune Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Xencor Inc | 8.22% | 1,885,533 | $14.90M | Insider |
| Raymond Joseph Tesi | 6.78% | 1,554,106 | $12.28M | Insider |
| Mark William Lowdell | 6.59% | 1,510,806 | $11.94M | Insider |
| David J. Moss | 5.61% | 1,285,869 | $10.16M | Insider |
| Blackrock Inc | 4.32% | 989,558 | $7.82M | Institution |
| Linda F. Powers | 3.97% | 910,000 | $7.19M | Insider |
| Praetorian Pr LLC | 3.54% | 812,210 | $6.42M | Institution |
| Vanguard Group Inc | 3.22% | 738,201 | $5.83M | Institution |
| Raymond James Financial Inc | 2.07% | 475,551 | $3.76M | Institution |
| Geode Capital Management LLC | 1.59% | 363,602 | $2.87M | Institution |
INMB vs Biotech Stocks
Inmune Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.